Abstract
The Global HIV Vaccine Enterprise convened a workshop in September 2009 to discuss human and viral genetic variation and its impact on future directions for HIV vaccine research and development. The formidable challenges presented by virus and host genetic variability are interrelated and complicate vaccine development. HIV vaccine researchers need to develop innovative approaches that will facilitate addressing these questions in novel ways.
Similar content being viewed by others
Article PDF
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
McMichael, A., McCutchan, F. & Working Group convened by the Global HIV Vaccine Enterprise, t. Host Genetics and Viral Diversity: Report from a Global HIV Vaccine Enterprise Working Group. Nat Prec (2010). https://doi.org/10.1038/npre.2010.4797.1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/npre.2010.4797.1
